CTSV and lung cancer: Moreover, the high CTSV expression group showed lower levels of the StromalScore (Spearman R = −0.319), ImmuneScore (Spearman R = −0.403), and EstimateScore (Spearman R = −0.388) than that when compared with low expression CTSV group in lung cancer (Figure 7B–7E).